Ann: Commercial Partnership with Mobvoi for New Health Smartwatch, page-59

Current situation of Cardiex


✅ Cardiex is the only company that has FDA clearance for measuring central blood pressure, arterial stiffness non-invasively in adults.
✅ Disrupting a 100 year old health sector.
✅ One of the most undervalued stock on ASX.
✅ Huge potential with massive target market.
✅ Launch of new devices and associated software/ digital solutions coming into the market in 2020 & 21 with a great CEO at the helm with novel products in a new and exciting space.

Nothing has changed fundamentally. Just need patience here and we all be rewarded in a matter of time.

All in my opinion. Good luck to all.